Status:
SUSPENDED
Opioid Receptors Influence Ischemia-Reperfusion Injury
Lead Sponsor:
Radboud University Medical Center
Conditions:
Ischemia-Reperfusion Injury
Eligibility:
MALE
18-50 years
Phase:
NA
Brief Summary
The most powerful protective mechanism against ischemia-reperfusion injury other than rapid reperfusion is ischemic preconditioning. Ischemic preconditioning is defined as the development of tolerance...
Eligibility Criteria
Inclusion
- Healthy male volunteers
Exclusion
- Exposition to radiation due to imaging techniques in the previous five years
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00184938
Start Date
January 1 2005
Last Update
March 28 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud University Nijmegen Medical Centre / Department of Pharmacology and Toxicology
Nijmegen, Gelderland, Netherlands, 6500 HB